Jane M Tezapsidis

Picture of Jane Tezapsidis


Professor
Deputy Chairperson
Science

EMAIL: jtezapsidis@bmcc.cuny.edu

Office: N-698L

Office Hours:

Phone: +1 (212) 220-8000;ext=7457

Dr Jane M. Johnston (Tezapsidis) is regarded as an expert in molecular neuroscience relating to Alzheimer’s and Parkinson’s diseases, as well as pre-clinical drug development. She has garnered more than 25 years of research experience in cellular neuroscience and published more than 40 peer-reviewed articles in the field (download publication list below).
Dr Tezapsidis has been teaching Anatomy/Physiology and Pharmacology at BMCC since 2005. She has also served as an Adjunct Professor in the graduate Physiology and Pharmacology program at Rutgers New Jersey Medical School, and in the Albert Einstein College of Medicine in Bronx, New York. In addition to her academic positions, she has consulted for industry at Johnson & Johnson and conducts drug development at Neurotez, a biotechnology company based in New Jersey.
Dr Tezapsidis graduated with a Ph.D. in Biochemistry from the Imperial College of Science, Technology and Medicine at the University of London, and she was a Visiting Fellow at the National Institutes of Neurological Disorders and Stroke at the National Institutes of Health (NIH) in Bethesda Maryland.

Expertise

Cellular biology, molecular biology, microbiology

Degrees

  • Ph.D. Imperial College of Science, Technology and Medicine/Univ. of London, Biochemistry,

Courses Taught

BIO 220 (Biology II)

Research and Projects

Publications

  • ,
  • ,
    Download

Honors, Awards and Affiliations

Additional Information

FUNDED RESEARCH

2018-2019 PSC-CUNY Research Award Forskolin induces apoptosis in SH-SY5Y neuroblastoma Cells

2014-2015 BMCC Faculty Publication Award Improving viability of dopaminergic neurons in culture

2010-2011 Bridge Award New Jersey Commission on Science and Technology Role: Co-director. Director: Nikolaos Tezapsidis Ph.D.

2008-2010 Postdoctoral Fellowship Award (for Steven Greco), New Jersey Commission on Science and Technology .Role: Co-director. Director Nikolaos Tezapsidis Ph.D

2007-2013 (R43, R44 AG029670), National Institutes of Health Leptin as a Treatment for Alzheimer’s DiseaseRole: Co-PI. PI: Tezapsidis

2008-2009 PSC-CUNY (69864 -00 39) Faculty in Service Award

2007-2008 PSC-CUNY (69864-00 38) Faculty in Service Award

1997-2000 The Alzheimer’s Association Presenilins and Alzheimer’s Disease (3 years). Role: Co-PI with Dr. N. Tezapsidis, Mt. Sinai School of Medicine, N.Y.

1993-1994 Molecular and Cellular Neurobiology Fellowship(2 years). Fogarty International Center. National Institutes of Health Sponsored by Dr. J.W. Commission. National Institute for Neurological Disorders and Stroke, Bethesda, Maryland.

1992 Regional Research Committee, North West Thames Regional Health Authority, London U.K. Abnormalities of the Human Pituitary Dopamine D2 Receptor (ref C16/17)